The efficacy and safety of risperdal in the treatment of irritability associated with autistic disorder were established in two 8-week, double-blind, placebo-controlled trials in 156 children and adolescent patients, aged 5 to 16 years see indications and usage , adverse reactions and clinical studies .
Continue reading→

Risperdal could never replace haldol as johnson johnson s latest bestseller if it was sold as only appropriate for psychotic disorders.
Continue reading→

Mild cases were considered to be as harmful as moderate or severe cases of risperdal gynecomastia.
Continue reading→